| Literature DB >> 25985312 |
Hyeon-Yeong Kim1, Sae-Mi Shin2, Miran Ham3, Cheol-Hong Lim4, Sang-Hoon Byeon5.
Abstract
This study was performed to assess exposure to and the risk caused by biphenyl in the workplace. Biphenyl is widely used as a heat transfer medium and as an emulsifier and polish in industry. Vapor or high levels of dust inhalation and dermal exposure to biphenyl can cause eye inflammation, irritation of respiratory organs, and permanent lesions in the liver and nervous system. In this study, the workplace environment concentrations were assessed as central tendency exposure and reasonable maximum exposure and were shown to be 0.03 and 0.12 mg/m³, respectively. In addition, the carcinogenic risk of biphenyl as determined by risk assessment was 0.14 × 10⁻⁴ (central tendency exposure) and 0.56 × 10⁻⁴ (reasonable maximum exposure), which is below the acceptable risk value of 1.0 × 10⁻⁴. Furthermore, the central tendency exposure and reasonable maximum exposure hazard quotients were 0.01 and 0.06 for oral toxicity, 0.05 and 0.23 for inhalation toxicity, and 0.08 and 0.39 for reproduction toxicity, respectively, which are all lower than the acceptable hazard quotient of 1.0. Therefore, exposure to biphenyl was found to be safe in current workplace environments. Because occupational exposure limits are based on socioeconomic assessment, they are generally higher than true values seen in toxicity experiments. Based on the results of exposure monitoring of biphenyl, the current occupational exposure limits in Korea could be reviewed.Entities:
Keywords: biphenyl; carcinogen; exposure; industrial; response; toxicity
Mesh:
Substances:
Year: 2015 PMID: 25985312 PMCID: PMC4454958 DOI: 10.3390/ijerph120505116
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Correction factors for deriving the reference concentration for work.
| Steps | Categories | KOSHA (Korea) | EPA (United States) | ECHA (European Union) | MHLW (Japan) |
|---|---|---|---|---|---|
| Quantitative correction | NOAELADJ | 0.5 | 0.17 | 0.5 | 0.5 |
| NOAELHEC | 1 | 1 | 1 | 1 | |
| Uncertain correction | Interspecies | 3 | 3 | 2.5 | 10 |
| Intraspecies | 5 | 10 | 5 | 1 | |
| Duration | 2 | 3 | 2 | 1 | |
| Severity | 1 | 1 | 1 | 1 | |
| Quality | 1 | 1 | 1 | 1 |
KOSHA: Korea Occupational Safety & Health Agency; EPA: Environmental Protection Agency; ECHA: European Chemicals Agency; MHLW: Ministry of Health, Labour and Welfare; NOAELADJ: no observed adverse effect level of the adjusted for duration; NOAELHEC: no observed adverse effect level of the adjusted to a human equivalent concentration.
Unit risk for carcinogenic dose-response assessment of biphenyl.
| Steps | Categories | Values (per mg/kg-day) |
|---|---|---|
| Slope factor | BMDL | 8.2 × 10−3 |
| IUR | IUR = (SF × IR)/BW | 2.3 × 10−3 |
| URwork | URwork = IUR/CFa | 4.7 × 10−4 |
Notes: BMDL: lower confidence limit of the benchmark dose; IUR: inhalation unit risk; SF: slope factor; IR (inspirable rate): 20 m3/day; BW: body weight (mean weight of an American worker: 70 kg); URwork: unit risk in the workplace. aCF (correction factor):
Reference values for non-carcinogenic dose-response assessment of biphenyl
| Steps | Categories | Values | |||
|---|---|---|---|---|---|
| Toxicity | Special target organ toxicity (oral toxicity) | Special target organ toxicity (inhalation toxicity) | Reproductive toxicity | ||
| POD | BMDL 23 mg/kg-day (rat, oral) | LOAEL 157.75 mg/m3 (rat, inhalation) | BMDL 20 mg/kg-day (rat, oral) | ||
| Route-to-route extrapolation | Dose scaling from animals to humans | 4 | — | 4 | |
| Quantitative correction | NOAELADJ | 0.5 | 0.5 | 0.5 | |
| NOAELHEC | 1 | 1 | 1 | ||
| Uncertain correction | Interspecies | 3 | 3 | 3 | |
| Intraspecies | 5 | 5 | 5 | ||
| Duration | ≥4 weeks | 6 | 6 |
| |
| ≥13 weeks | 2 |
| 2 | ||
| ≥6 months |
| 1 | 1 | ||
| Severity | NOAEL |
| 1 |
| |
| LOAEL | 5 |
| 5 | ||
| Quality | 1 | 1 | 1 | ||
| RfCwork (mg/m3) | 2.13 | 0.53 | 0.31 | ||
POD: point of departure; BMDL: lower confidence limit of the benchmark dose; LOAEL: lowest observed adverse effect level; NOAELADJ: no observed adverse effect level of the adjusted for duration; NOAELHEC: no observed adverse effect level of the adjusted to a human equivalent concentration; NOAEL: no observed adverse effect level; RfCwork: reference concentrations in the workplace.
The exposure measurement data of workplace environments.
| Workplaces | N * | AM ** (mg/m3) | SD † (mg/m3) | Range (mg/m3) |
|---|---|---|---|---|
| A | 12 | 0.034 | 0.048 | 0.001–0.145 |
| B | 14 | 0.014 | 0.022 | 0.001–0.057 |
| C | 12 | 0.066 | 0.075 | 0.001–0.240 |
| Total | 38 | 0.038 | 0.048 | 0.001–0.240 |
Notes: * the number of data points used to calculate AM and SD. ** AM: Arithmetic mean. SD: standard deviation.
Calculated risk values of biphenyl.
| Categories | ECR (Carcinogenicity) | HQ (Reproductive Toxicity) | HQ (Oral Toxicity) | HQ (Inhalation Toxicity) |
|---|---|---|---|---|
| CTE | 0.14 × 10−4 | 0.08 | 0.01 | 0.05 |
| RME | 0.56 × 10−4 | 0.39 | 0.06 | 0.23 |
| OEL | 7.05 × 10−4 | 4.8 | 0.7 | 2.8 |
Notes: CTE: central tendency exposure; RME: reasonable maximum exposure; OEL: occupational exposure limit; ECR: excess cancer risk; HQ: hazard quotient.